Resources Contact Us Home
Recombinant toxin fragments

Image Number 4 for United States Patent #8017134.

A single polypeptide is provided which comprises first and second domains. The first domain enables the polypeptide to cleave one or more vesicle or plasma-membrane associated proteins essential to exocytosis, and the second domain enables the polypeptide to be translocated into a target cell or increases the solubility of the polypeptide, or both. The polypeptide thus combines useful properties of a clostridial toxin, such as a botulinum or tetanus toxin, without the toxicity associated with the natural molecule. The polypeptide can also contain a third domain that targets it to a specific cell, rendering the polypeptide useful in inhibition of exocytosis in target cells. Fusion proteins comprising the polypeptide, nucleic acids encoding the polypeptide and methods of making the polypeptide are also provided. Controlled activation of the polypeptide is possible and the polypeptide can be incorporated into vaccines and toxin assays.

  Recently Added Patents
Hydrogen generation device and fuel cell system
Quick mounting device
Display screen with transitional icon
Eyeglass component
Method and a channel estimating arrangement for performing channel estimation
Liquid-level sensor
Image forming system, printing control method, and program
  Randomly Featured Patents
Unit integrated system and connector
Approach for fast IP address lookups
Electronic parts
Spring brake cylinder
Portable tree stand
Electroerosion machine for wire cutting a stationary workpiece
Method for growth of a hydraulic fracture along a well bore annulus and creating a permeable well bore annulus
Spherical ferrite particles and ferrite resin composite for bonded magnetic core
Holder for pocket square
Preparation of diacyloxyhexadienes from hexatrienes